GlassScriptPhysician profile
Nicole A Novak
NPI 1811424609
$4,668.25
in general payments reported to CMS, 2019-2025
14 companies · $3,362 in 2025
The $3,362 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $117 · 2022: $256 · 2023: $423 · 2024: $511 · 2025: $3,362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,934 · Travel and Lodging: $1,362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,933.60 |
| Travel and Lodging | $1,361.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $2,395.27 | 2025 | Evoke |
| Nevro Corp. | $794.79 | 2021-2024 | Senza |
| Boston Scientific Corporation | $290.40 | 2023-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $238.38 | 2022-2025 | Proclaim |
| Medtronic, INC. | $202.07 | 2024-2025 | Intellis Adaptivestim, Inceptiv |
| Spinal Simplicity, LLC | $158.51 | 2025 | Ha Minuteman G3-R |
| Vertex Pharmaceuticals Incorporated | $153.54 | 2025 | |
| Collegium Pharmaceutical, INC. | $123.92 | 2022-2025 | Belbuca |
| Globus Medical, INC. | $83.19 | 2025 | Senza |
| Si-Bone, INC. | $64.30 | 2025 | |
| Tersera Therapeutics LLC | $62.33 | 2024-2025 | Prialt |
| Abbvie INC. | $43.84 | 2025 | |
| Valinor Pharma, LLC | $39.40 | 2025 | Movantik |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.31 | 2025 | Relistor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Novak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.